started · updated
Heidi Overton nominated by Trump to lead the FDA
President Donald Trump intends to nominate White House policy aide Dr. Heidi Overton as the next commissioner of the Food and Drug Administration (FDA). Overton, a physician and current deputy assistant for domestic policy, was selected over other candidates including Stephen Ferrara and Jeff Vacirca.
Overton's nomination has drawn attention from pro-life advocates. John Mize, CEO of Americans United for Life, expressed optimism that her leadership could lead to renewed scrutiny of the abortion drug mifepristone. Overton's appointment follows the resignation of former commissioner Martin Makary in mid-May.
If confirmed, Overton will oversee critical agency functions, including the Center for Tobacco Products. Recent efforts by the Center have included a 70 percent reduction in the backlog of premarket tobacco product applications during 2025. Her administration will also work alongside HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz to address drug prices and clinical trial reforms.
Entities
Americans United for Life · Donald Trump · Food and Drug Administration · Heidi Overton · John Mize · Mehmet Oz · Robert F. Kennedy Jr.
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] Trump described Overton as a 'ROCKSTAR' who will help ensure the U.S. remains a world leader in scientific discovery and cures. www.agencyiq.com
- [● 2 SOURCES] John Mize, CEO of Americans United for Life, believes Overton could bring renewed scrutiny to the abortion drug mifepristone. offthepress.com · nypost.com
- [● 4 SOURCES] President Donald Trump plans to nominate White House policy aide Heidi Overton to lead the FDA. www.agencyiq.com · offthepress.com · taxfoundation.org · nypost.com
- [○ 1 SOURCE] The FDA's Center for Tobacco Products reduced the backlog of premarket tobacco product applications by approximately 70 percent in 2025. taxfoundation.org